FinancialsInvestment Banking and Brokerage Services
  • Price (USD)74.63
  • Today's Change0.38 / 0.51%
  • Shares traded2.45m
  • 1 Year change+2.22%
  • Beta1.5882
Data delayed at least 15 minutes, as of Jun 07 2023 21:10 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

State Street Corporation is a financial holding company. The Company, through its subsidiary, State Street Bank and Trust Company (State Street Bank), provides a range of financial products and services to institutional investors. It operates through two lines of business: Investment Servicing and Investment Management. Its Investment Servicing, through State Street Investment Services, State Street Global Markets, and State Street Alpha, provides investment services for clients, including mutual funds, collective investment funds and other investment pools. Its products include back-office products, such as custody, accounting, regulatory reporting, and investor services. Its Investment Management line of business, through State Street Global Advisors, provides a range of investment management strategies and products for its clients. It offers a breadth of services and solutions, including ESG investing, defined benefit and defined contribution products and Global Fiduciary Solutions.

  • Revenue in USD (TTM)5.59bn
  • Net income in USD2.60bn
  • Incorporated1969
  • Employees42.79k
  • Location
    State Street Corp1 Congress Street, Suite 1BOSTON 02114United StatesUSA
  • Phone+1 (617) 786-3000
  • Fax+1 (617) 654-3386
  • Websitehttps://www.statestreet.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
STT:NYQ since
CF Global Trading LLCDeal completed22 Mar 202322 Mar 2023Deal completed-2.72%--
Data delayed at least 15 minutes, as of Jun 07 2023 21:10 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
(YOY change %)
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
(5 yr growth rate)
Royalty Pharma plc2.36bn331.83m20.55bn75.0044.823.4533.628.710.75510.75514.179.800.1370--69.8531,455,160.003.55--4.89------25.9069.72----0.420314.97-2.286.96-93.09-48.74-5.33--
State Street Corp5.59bn2.60bn24.82bn42.79k10.401.106.712.047.147.1433.4173.56--------0.88690.9133--------22.3921.24------31.82107.947.333.423.602.888.45
Data as of Jun 07 2023. Currency figures normalised to State Street Corp's reporting currency: US Dollar USD

Institutional shareholders

40.50%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 31 Mar 202340.62m11.79%
Dodge & Coxas of 31 Mar 202321.83m6.34%
BlackRock Fund Advisorsas of 31 Mar 202317.57m5.10%
SSgA Funds Management, Inc.as of 31 Mar 202316.20m4.70%
Columbia Management Investment Advisers LLCas of 31 Mar 20238.03m2.33%
Longview Partners LLPas of 31 Mar 20237.91m2.30%
Geode Capital Management LLCas of 31 Mar 20237.40m2.15%
Invesco Advisers, Inc.as of 31 Mar 20237.10m2.06%
Capital Research & Management Co. (International Investors)as of 31 Mar 20236.55m1.90%
T. Rowe Price Associates, Inc. (Investment Management)as of 31 Mar 20236.32m1.84%
More ▼
Data from 31 Mar 2023 - 31 Mar 2023Source: FactSet Research Systems Inc.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.